Head-to-head · WeighScore
Fierce Health vs RedBox Rx
The verdict
RedBox Rx takes it — 70.2/100 to 56.6/100.
RedBox Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RedBox Rx is a US telehealth pharmacy (parent company Hy-Vee) offering compounded GLP-1 weight management with flat, dose-independent pricing.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Fierce Health | RedBox Rx |
|---|---|---|
| WeighScore | 56.6/100 | 70.2/100 |
| Grade | C | C |
| Scorecard rank | #410 | #105 |
| Semaglutide | $297/mo (3-month plan, compounded) | $269/mo (all doses, 6-month plan, compounded) |
| Tirzepatide | $497/mo (3-month plan, compounded) | $429/mo |
| Coverage | 30 states | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #410 · C
Strengths
- 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer on every product page
- Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
- Microdose tier at $197/mo is one of the lower entry points we've seen
Where it loses points
- No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
- Operating LLC name not disclosed anywhere on the site
- Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
- Clinical provider network not named
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Graded #105 · C
Strengths
- Flat, dose-independent pricing on both semaglutide and tirzepatide
- Offers both weekly injections and daily oral tablets
- Includes unlimited provider follow-ups, a metabolic panel and a dietitian session
- Backed by grocery-pharmacy parent company Hy-Vee
Where it loses points
- Does not serve every state (for example Mississippi is excluded)
- Does not publicly name its compounding pharmacy
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.